首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1516032

电子临床结果评估 (eCOA) 解决方案市场 - 按类型、部署模型、服务类型、最终用途和预测，2024 年 - 2032 年

Electronic Clinical Outcome Assessment (eCOA) Solution Market - By Type, Deployment Model, Service Type, End-use & Forecast, 2024 - 2032

出版日期: 2024年04月01日 | 出版商:

Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于完善的医疗基础设施和政府推动数位医疗技术的积极倡议，全球电子临床结果评估 (eCOA) 解决方案市场在 2024 年至 2032 年期间将以 14.3% 的复合年增长率增长。慢性病盛行率的不断上升是市场成长的主要动力。据世界卫生组织称，非传染性疾病 (NCD) 每年夺去 4,100 万人的生命，占全球死亡人数的 74%。随着人口老化和生活方式的改变，糖尿病、心血管疾病、呼吸系统疾病等慢性疾病呈现上升趋势。

随着这些疾病的负担不断增加，需要更有效的方法来监测患者的结果和治疗效果。 eCOA 解决方案透过实现远端资料收集、即时监控和个人化干预，为慢性病管理提供主动方法。透过促进及时介入和改善患者管理，eCOA 解决方案在应对慢性病盛行率日益上升的挑战方面发挥着至关重要的作用，从而促进市场成长。

电子临床结果评估 (eCOA) 解决方案产业根据类型、部署模型、服务类型、最终用途和区域进行分类。

临床报告结果 (ClinRO) 部分将在 2032 年之前稳定成长，因为 ClinRO 评估提供了有关介入措施对临床状态和患者整体健康影响的宝贵资讯。此外，它们的需求更大，因为它们可以直接从患者收集临床相关资料。透过这种方式，卫生专业人员可以准确评估疾病的严重程度、治疗的有效性以及患者描述的症状。此外，ClinRO 评估提供的灵活性，允许问卷适应特定的治疗领域，促进了其在各种临床试验中的采用。

随着医疗保健提供者使用 eCOA 解决方案来追踪患者结果、追踪疾病进展和优化治疗策略，医疗保健提供者细分市场的电子临床结果评估市场将在 2032 年强劲成长。随着我们转向基于价值的护理和以患者为中心的医疗保健提供模式，医疗保健提供者越来越多地使用 eCOA 解决方案来改善患者护理和临床结果。此外，eCOA资料与电子健康记录 (EHR) 的整合可实现无缝资料交换和互通性，从而促进医疗保健提供者采用 eCOA 解决方案。

由于完善的医疗基础设施和政府推动数位医疗技术的积极倡议，欧洲电子临床结果评估产业将在 2032 年快速成长。英国、德国和法国等国家处于 eCOA 采用的前沿，并且越来越多地投资于临床试验和研究。欧洲严格的监管环境确保了资料保护和资料安全的高标准，增强了利害关係人的信心，并促进了 eCOA 解决方案的广泛采用。此外，学术界、工业界和监管机构之间的合作将推动创新并加速先进 eCOA 技术的开发和采用，从而推动市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 从纸本程式逐渐转向电子资料收集
  - eCOA 模式不断进步
  - 越来越多地采用基于云端的服务
  - 政府对临床试验的有利支持与资助
- 产业陷阱与挑战
  - 操作 eCOA 的熟练专业人员严重缺乏
  - 对资料安全和隐私的担忧
成长潜力分析
技术景观
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
临床医师报告的结果 (ClinRO)
患者报告的结果 (PRO)
观察员报告结果 (ObsRO)
绩效结果 (PerfO)

第 6 章：市场估计与预测：按部署模型，2021 - 2032 年

主要趋势
获得许可的企业（本地）解决方案
基于云端的解决方案
网页寄存（按需）解决方案

第 7 章：市场估计与预测：按服务类型，2021 - 2032 年

主要趋势
自带装置模型 (BYOD)
已配置的设备型号

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
製药和生物製药公司
医疗保健机构
- 医院
- 诊所
合约研究组织 (CRO)
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 10 章：公司简介

AssisTek
Climedo Health GmbH
Clinical ink
CRF Health
EvidentIQ
ICON plc
IQVIA
Integra IT S.A.S
Kayentis
Medidata
Oracle Corporation
Raylytic GmbH
Signant Health
Veeva Systems

简介目录

Product Code: 8777

Global Electronic Clinical Outcome Assessment (eCOA) solutions market will grow at 14.3% CAGR during 2024-2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. The increasing prevalence of chronic diseases is acting as a major driver for market growth. According to the WHO, non-communicable diseases (NCDs) claim 41 million lives each year, accounting for 74 percent of global deaths. As the population ages and lifestyles change, chronic diseases such as diabetes, cardiovascular diseases, and respiratory diseases are on the rise.

As the burden of these diseases continues to increase, more effective methods are needed to monitor patient outcomes and treatment efficacy. eCOA solutions provide a proactive approach to chronic disease management by enabling remote data collection, real-time monitoring, and personalized interventions. By facilitating timely intervention and improving patient management, eCOA solutions play a crucial role in addressing the challenges of the increasing prevalence of chronic diseases, thereby inducing market growth.

Electronic Clinical Outcome Assessment (eCOA) Solutions industry is classified based on type, deployment model, service type, end use, and region.

The Clinical-Reported Outcomes (ClinRO) segment will grow steadily through 2032, as ClinRO assessments provide valuable information about the impact of interventions on clinical status and the general well-being of patients. In addition, they are more in demand because they can collect clinically relevant data directly from patients. In this way, health professionals can accurately assess the severity of the disease, the effectiveness of the treatment, and the symptoms described by the patient. In addition, the flexibility offered by ClinRO assessments, allowing questionnaires adapted to specific treatment areas, promotes their adoption in various clinical trials.

The electronic clinical outcome assessment market from the healthcare provider segment will grow strongly through 2032 as healthcare providers use eCOA solutions to track patient outcomes, track disease progression, and optimize treatment strategies. As we move towards value-based care and patient-centered healthcare delivery models, healthcare providers are increasingly using eCOA solutions to improve patient care and clinical outcomes. In addition, the integration of eCOA data with electronic health records (EHR) enables seamless data exchange and interoperability, which promotes the adoption of eCOA solutions among healthcare providers.

Europe Electronic Clinical Outcome Assessment industry will grow rapidly through 2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. Countries such as the UK, Germany, and France are at the forefront of eCOA adoption and are increasingly investing in clinical trials and research. Europe's strict regulatory environment ensures high standards of data protection and data security, increases stakeholder confidence, and promotes the widespread adoption of eCOA solutions. In addition, collaboration between academia, industry, and regulatory agencies will drive innovation and accelerate the development and adoption of advanced eCOA technologies that will drive market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Gradual shift towards electronic data capturing from paper-based procedures
  - 3.2.1.2 Growing advancements in eCOA modalities
  - 3.2.1.3 Growing adoption of cloud-based services
  - 3.2.1.4 Favorable government support and funding for clinical trials
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High dearth of skilled professionals to operate eCOA
  - 3.2.2.2 Concern about data security and privacy
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Clinician-reported outcome (ClinRO)
5.3 Patient-reported outcome (PRO)
5.4 Observer-reported outcome (ObsRO)
5.5 Performance outcome (PerfO)

Chapter 6 Market Estimates and Forecast, By Deployment Model, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Licensed enterprise (on-premises) solutions
6.3 Cloud-based solutions
6.4 Web-hosted (on-demand) solutions

Chapter 7 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Bring-your own device model (BYOD)
7.3 Provisioned device model

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biopharmaceutical companies
8.3 Healthcare providers
- 8.3.1 Hospitals
- 8.3.2 Clinics
8.4 Contract research organizations (CROs)
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa